GLP-1 Digest

GLP-1 Digest

Home
Podcast
Archive
Leaderboard
About
53:20
🎧 Genetics Could Decide Who Wins the GLP-1 Market, Ep. 7 with 23andMe’s Dr. Adam Auton
Predicting weight loss and side effects before treatment begins
Jun 14 • Ashwin Sharma, MD
🎧 Can Peptides Become a Real DTC Business? Ep.6 with Tim Gutwald
Before they become a real revenue stream, founders need to solve three unsexy problems
May 17 • Ashwin Sharma, MD
58:47
🎧 GLP-1s Are Coming for the Snack Aisle, Ep. 5 with Henry Dimbleby
On shrinking food volumes, and why consumers want more value per bite
May 3 • Ashwin Sharma, MD
53:37
What happens when GLP-1s go off-patent?
Five charts that’ve caught my eye
Apr 26 • Ashwin Sharma, MD
🎧 Can GLP-1s Save the NHS? Ep. 4 with Lord James Bethell
Healthspan is decreasing in the UK, and the private market could help turn things around
Apr 12 • Ashwin Sharma, MD
41:12
India is not the opportunity you think it is
Why DTC telehealth won't work in India's GLP-1 market
Mar 26 • Ashwin Sharma, MD
🎧 Should GLP-1s be sold over the counter? Ep 3, with Dr. Beverly Tchang, MD
On the maintenance trap, microdosing for prevention, and frictionless access
Mar 8 • Ashwin Sharma, MD
1:19:22
🎧 What investors get wrong about Hims & Hers, Ep. 2 with Paul Cerro
Listen now | The definitive Q4 2025 earnings breakdown
Mar 1 • Ashwin Sharma, MD
1:09:46
GLP-1 Digest
GLP-1 Digest
The GLP-1 newsletter for founders, operators and investors.
Recommendations
View all 6
In-Network
In-Network
David Ohta
The Gut Group
The Gut Group
Dr Arif Hussenbux MBBS
Breakthrough
Breakthrough
Samuel Hume
Big Pharma Sharma
Big Pharma Sharma
Big Pharma Sharma
The Argument
The Argument
The Argument

GLP-1 Digest

AboutArchiveRecommendationsSitemap
© 2026 Ashwin Sharma · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture